The landscape of dementia diagnosis has evolved considerably with the appearance of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-based tests that may detect Alzheimer's pathology a long time just before signs emerge. While these technological advances represent outstanding progress in being familiar with neurodegenerative diseases, they may https://carlosl420juc9.dm-blog.com/profile